Alcami Expands Lab Services: A Commitment to Innovation
Alcami Expands Laboratory Services in Durham
Alcami Corporation, a prominent U.S.-based contract development and manufacturing organization (CDMO), has announced its plans to expand laboratory services at its Creekstone Drive facility. This strategic move emphasizes Alcami's ongoing commitment to providing integrated solutions tailored for the pharmaceutical and biotech industries, facilitating efficient operations from development right through to delivery.
Details of the Expansion
The 20,000-square-foot addition to the facility aims to significantly enhance Alcami's analytical capabilities, especially in supporting crucial areas such as biologics, peptides, oligonucleotides, antibody-drug conjugates (ADCs), and cell and gene therapy (CGT). This expansion will incorporate advanced methodologies in bioseparation, mass spectrometry, electrophoresis, and bioassays, enabling more comprehensive research and testing. As a result, Alcami will be positioned to better serve its clients throughout all phases of drug development, from preclinical assessments to commercial supply.
Commitment to Scientific Excellence
"This investment exemplifies Alcami's dedication to scientific excellence and operational efficiency," expressed Katie Schlipp, President of Laboratory Services. She noted that expanding their capabilities will not only enhance operational agility but also empower clients to bring life-altering therapies to patients more rapidly.
Strategic Network of Facilities
The Creekstone Drive site is a vital element of Alcami's extensive network, which includes laboratories, manufacturing, and pharmaceutical storage locations strategically distributed throughout the United States. Alcami prioritizes quality and scalability, with laboratory services designed to integrate smoothly with their drug product manufacturing and pharma storage capabilities, providing clients with the option to streamline sourcing requirements.
Investments Across Alcami's Network
This expansion aligns with Alcami’s recent strategic investments across its network. Notable enhancements include sterile fill-finish capacity expansions at facilities in RTP, NC, and Charleston, SC, as well as improvements to oral solid dose capabilities in Wilmington, NC. These upgrades reflect Alcami's proactive approach to meeting the evolving needs of the pharmaceutical sector.
About Alcami Corporation
Alcami is a respected player in the pharmaceutical industry, headquartered in North Carolina with over 45 years of experience in advancing products from development to delivery. With a focus on fully integrated lab services, drug product manufacturing, cGMP pharma storage, and essential support services, Alcami collaborates closely with clients through each stage of the development process. The company is backed by private equity firms, including GHO Capital, The Vistria Group, and Ampersand Capital Partners, securing its resources for continued growth and innovation.
Frequently Asked Questions
What is Alcami Corporation known for?
Alcami is a contract development and manufacturing organization focused on providing integrated lab services and solutions for the pharmaceutical and biotech industries.
Where is the Creekstone Drive facility located?
The Creekstone Drive facility is located in Durham, North Carolina, and is a key site for Alcami's laboratory services expansion.
What types of services does Alcami provide?
Alcami offers a range of services, including lab services, drug product manufacturing, and cGMP pharma storage, to support pharmaceutical development.
What recent expansions has Alcami made?
Alcami has expanded its sterile fill-finish capacity and enhanced oral solid dose capabilities across several facilities in the United States.
How does Alcami ensure quality in its services?
Alcami maintains a strong focus on quality, integrating innovative practices in all aspects of its laboratory and manufacturing services to meet industry standards.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.